GSK-LSD1 dihydrochloride
CAS: 2102933-95-7
Ref. 3D-CJD93395
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Product Information
GSK-LSD1 is a potential drug for the treatment of cervical cancer and myeloid leukemia. GSK-LSD1 has been shown to induce autophagy, which is a process by which cells break down and recycle their own cellular components. This process also plays a key role in the development of bowel disease, as well as inflammatory bowel disease and leukemias. GSK-LSD1 was shown to inhibit the growth of human myeloid leukemia cells (THP-1) in vitro and reduced the number of leukemic mice with leukemia. The mechanism by which GSK-LSD1 inhibits tumor cell proliferation is unclear, but may be related to its ability to inhibit cell factor or stem cell factor expression.
Chemical properties
Technical inquiry about: 3D-CJD93395 GSK-LSD1 dihydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.